# UPPTHERA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/uppthera

- Industry: Pharmaceuticals
- Headquarters: Incheon, South Korea
- Website: www.uppthera.com
- Total disclosed funding: $40M
- Latest round: Series B (Jul 24, 2023)
- Investors on record: 10

## About

Based in Incheon, South Korea, and co-founded in 2018 by SiWoo Choi (CEO), SooHee Ryu, JiHoon Ryu, HwaJin Lee, SanHa Son, UPPTHERA, operates as a provider of healthcare platform that targets the treatment of small cell lung cancer, cardiovascular, and multiple myeloma diseases. The firm has offices in  Incheon and Daegu. In May 2022, UPPTHERA raised KRW 28 billion in series B funding from new investors Meritz Securities and Paratus Investment and returning investors Albatross Investment.

The firm develops a targeted protein degradation-based platform PROTAC that operates with the mechanism of ubiquitin-proteasome. The firm is also working on the development of Novel E3 ligase Platform as well as the UPPGRADER Platform.

The company intends to use the funds raised in May 2022 for research and development of potential material for small cell lung cancer (SCLC).

## Funding rounds

- Series B, Jul 24, 2023, $7.8M — YuanBio Venture
- Series B, May 18, 2022, $22M — SBI Investment Korea, Meritz Securities, KDB Capital, IMM Investment, Albatross Investment, Paratus Investment, Enlight Ventures
- Series A, Jul 15, 2020, $11M — SBI Investment Korea, KDB Capital, IMM Investment, Albatross Investment, Midas Donga Investment, Enlight Ventures
- Seed, May 1, 2019 — Korea Tech Incubator for Startup, Enlight Ventures

## Investors

- Korea Tech Incubator for Startup — Seed
- Enlight Ventures (https://capitalatlas.ai/funds/enlight-ventures) — Seed, Series A, Series B
- SBI Investment Korea (https://capitalatlas.ai/funds/sbi-investment-korea) — Series A, Series B
- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series A, Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series A, Series B
- Albatross Investment (https://capitalatlas.ai/funds/albatross-investment) — Series A, Series B
- Midas Donga Investment (https://capitalatlas.ai/funds/midas-donga-investment) — Series A
- Meritz Securities — Series B
- Paratus Investment (https://capitalatlas.ai/funds/paratus-investment) — Series B
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B